Malkeet Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Malkeet Kumar has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Anees Ahmad
Institute of Chemistry, University of Campinas, Barão Geraldo, PO Box 6154, Campinas, SP 13083-970, Brazil
1 shared publication - Anna Caroline Campos Aguiar
University of São Paulo
1 shared publication - Anwar Shamim
Instituto de Química, Universidade de São Paulo, São Paulo, Brazil
1 shared publication Barry Jones
Pharmaron U.K., West Hill Innovation Park, Hoddesdon EN11 9FH, U.K.
1 shared publication- Delphine Baud
Medicines for Malaria Venture
1 shared publication Dhelio B. Pereira
Centro de Pesquisa em Medicina Tropical
1 shared publication
Latest Publications
- Open Access
- 31 July 2025
- Published by American Chemical Society (ACS) in ACS Bio & Med Chem Au
- Vol. 5 (5) , 821-839
Indole-2-carboxamides Optimization for Antiplasmodial Activity
Malaria still stands out as one of the most devastating and prevalent diseases globally, where the rise of resistance to different antimalarial drugs in different regions has posed significant obstacles to global treatment and elimination. Consequently, there is a pressing need for the development of new antimalarial agents with novel modes of action. In this study, we report the identification and optimization of new indole-2-carboxamide derivatives where structural modifications have yielded new compounds 6x with enhanced potency (Pf3D7-IC50 ∼ 0.3 μM) and improved metabolic stability (hMics = 3 μL/min/mg), while also minimizing the human ether-a-go-go-related gene (hERG, IC50 > 20 μM) channel activity and cytotoxic effect on hepatic cells (CC50 > 30 μM). Mode-of-action investigations revealed that a representative compound from this series interfered with homeostasis of the parasite's digestive vacuole. However, cross-resistance was observed with resistant strains, which was linked to efflux pumps such as Plasmodium falciparum chloroquine resistance transporter (PfCRT). Despite this challenge, these indole-2-carboxamides provide versatile molecular templates for innovative medicinal chemistry to overcome cross-resistance while maintaining other attractive properties of this novel series.
- 31 July 2025
- Published by American Chemical Society (ACS) in ACS Bio & Med Chem Au
- Vol. 5 (5) , 821-839
Open AccessIndole-2-carboxamides Optimization for Antiplasmodial Activity
Malaria still stands out as one of the most devastating and prevalent diseases globally, where the rise of resistance to different antimalarial drugs in different regions has posed significant obstacles to global treatment and elimination. Consequently, there is a pressing need for the development of new antimalarial agents with novel modes of action. In this study, we report the identification and optimization of new indole-2-carboxamide derivatives where structural modifications have yielded new compounds 6x with enhanced potency (Pf3D7-IC50 ∼ 0.3 μM) and improved metabolic stability (hMics = 3 μL/min/mg), while also minimizing the human ether-a-go-go-related gene (hERG, IC50 > 20 μM) channel activity and cytotoxic effect on hepatic cells (CC50 > 30 μM). Mode-of-action investigations revealed that a representative compound from this series interfered with homeostasis of the parasite's digestive vacuole. However, cross-resistance was observed with resistant strains, which was linked to efflux pumps such as Plasmodium falciparum chloroquine resistance transporter (PfCRT). Despite this challenge, these indole-2-carboxamides provide versatile molecular templates for innovative medicinal chemistry to overcome cross-resistance while maintaining other attractive properties of this novel series.